Atlas Trials

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

Clinical trial NCT01863758 · COMPLETED

Trial details

NCT number
NCT01863758
Sponsor
Octapharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Severe Haemophilia A
Start date
2013-08-01
Primary completion
2015-01-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.